Wiktor Wesołowski - Toxicology

Author Information

Wiktor Wesołowski is a distinguished researcher affiliated with the Department of Toxicology at the Faculty of Pharmacy, Medical University of Lodz, located in Lodz, Poland. His extensive research primarily revolves around toxicology and the analysis of various chemical substances, particularly focusing on their composition and potential health impacts. His work is of significant relevance in both occupational health and the study of natural compounds.

Research Contributions

Wiktor Wesołowski has contributed significantly to the field of toxicology through his research on the chemical composition and health effects of various substances. His work includes studies on essential oils, e-cigarette liquid compositions, and occupational exposure to hazardous substances such as diisocyanates and inhalatory anesthetics. Notably, he has explored the health risks associated with surgical smoke and the exposure of healthcare workers to sevoflurane. His research has been pivotal in understanding the potential risks and safety measures needed to protect workers and consumers from harmful chemical exposures.

Aliases

Wiktor Wesołowski is known by several aliases in academic circles, including W. Wesołowski, W Wesołowski, W J Wesołowski, Wiktor Wesolowski, and W Wesolowski. These variations are often found in his publications and citations across different databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	835
h-index	15
Total Paper Count	37

Publications:

A Comparison of the Composition of Selected Commercial Sandalwood Oils with the International Standard

DOI: 10.3390/molecules26082249

Year: 2021

2,3,7,8-Tetrachlorodibenzo-p-dioxin. Determining in workplace air with gas chromatography – mass spectrometry

DOI: 10.5604/01.3001.0013.4182

Year: 2019

[Analysis of volatile ingredients of selected essential oils listing relaxing action].

DOI: 10.13075/mp.5893.00784

Year: 2019

[Comparison of chemical composition of selected essential oils used in respiratory diseases].

DOI: 10.13075/mp.5893.00673

Year: 2018

Metabolite Profiling of Eastern Teaberry (Gaultheria procumbens L.) Lipophilic Leaf Extracts with Hyaluronidase and Lipoxygenase Inhibitory Activity

DOI: 10.3390/molecules22030412

Year: 2017

[Testing of the composition of e-cigarette liquids - Manufacturer-declared vs. true contents in a selected series of products].

DOI: 10.13075/mp.5893.00365

Year: 2016

Application of predictive models for estimation of health care workers exposure to sevoflurane

DOI: 10.1080/10803548.2015.1086183

Year: 2015

Occupational exposure to diisocyanates in polyurethane foam factory workers.

DOI: 10.13075/ijomeh.1896.00284

Year: 2015

Health risk to medical personnel of surgical smoke produced during laparoscopic surgery.

DOI: 10.13075/ijomeh.1896.00374

Year: 2015

[Assessment of occupational exposure of medical personnel to inhalatory anesthetics in Poland].

DOI: 10.13075/MP.5893.2014.010

Year: 2014

What are the initial steps in managing a toxic exposure?

How Does Technology Influence Pharmaceutical Analysis?

What are the long-term effects of MDPV use?

What is the Role of Toxicology in Understanding Hormone Mimetics?

How Is Hepatic Impairment Diagnosed?

What Are the Symptoms of Toxic Damage to Blood Vessels?

How is Toxic Pneumonitis Diagnosed?

Who Should Avoid Creatine?

What Role Does the Liver Play in the Coagulation Cascade?

How is antidepressant toxicity managed?

Partnered Content Networks

Relevant Topics